DAY 3 – WEDNESDAY 28 FEBRUARY 2018
PLENARY SESSION 7: CELL THERAPY
- Clinical-case Examples – Christoph Scheid (University Clinic of Cologne, DE)
- Early CAR-T Development Experience from an Academic Perspective – Jakub Svoboda (University of Pennsylvania, USA)
- Dendritic Cells – Jolanda De Vries (Radboud Institute for Molecular Life Sciences, NL)
- Technical Development – Mark Lowdell (Centre for Cell, Gene & Tissue Therapeutics, UK)
- Challenges with CAR T Cells: a European Regulatory Perspective – Martina Schussler-Lenz (Paul-Ehrlich-Institut, DE)
- Clinical Considerations for Cancer Cell Therapy: US FDA Perspective – Ke Liu (FDA, USA)